Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Metformin prevents the development of chronic heart failure in the SHHF rat model.

Cittadini A, Napoli R, Monti MG, Rea D, Longobardi S, Netti PA, Walser M, Samà M, Aimaretti G, Isgaard J, Saccà L.

Diabetes. 2012 Apr;61(4):944-53. doi: 10.2337/db11-1132. Epub 2012 Feb 16.

PMID:
22344560
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Metformin improves cardiac function in rats via activation of AMP-activated protein kinase.

Wang XF, Zhang JY, Li L, Zhao XY, Tao HL, Zhang L.

Clin Exp Pharmacol Physiol. 2011 Feb;38(2):94-101. doi: 10.1111/j.1440-1681.2010.05470.x.

PMID:
21143620
[PubMed - indexed for MEDLINE]
3.

Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure.

Yin M, van der Horst IC, van Melle JP, Qian C, van Gilst WH, Silljé HH, de Boer RA.

Am J Physiol Heart Circ Physiol. 2011 Aug;301(2):H459-68. doi: 10.1152/ajpheart.00054.2011. Epub 2011 May 13.

PMID:
21572014
[PubMed - indexed for MEDLINE]
Free Article
4.

Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase.

Sasaki H, Asanuma H, Fujita M, Takahama H, Wakeno M, Ito S, Ogai A, Asakura M, Kim J, Minamino T, Takashima S, Sanada S, Sugimachi M, Komamura K, Mochizuki N, Kitakaze M.

Circulation. 2009 May 19;119(19):2568-77. doi: 10.1161/CIRCULATIONAHA.108.798561. Epub 2009 May 4.

PMID:
19414638
[PubMed - indexed for MEDLINE]
Free Article
5.

Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitus.

van der Meer RW, Rijzewijk LJ, de Jong HW, Lamb HJ, Lubberink M, Romijn JA, Bax JJ, de Roos A, Kamp O, Paulus WJ, Heine RJ, Lammertsma AA, Smit JW, Diamant M.

Circulation. 2009 Apr 21;119(15):2069-77. doi: 10.1161/CIRCULATIONAHA.108.803916. Epub 2009 Apr 6.

PMID:
19349323
[PubMed - indexed for MEDLINE]
Free Article
6.

Direct demonstration of lipid sequestration as a mechanism by which rosiglitazone prevents fatty-acid-induced insulin resistance in the rat: comparison with metformin.

Ye JM, Dzamko N, Cleasby ME, Hegarty BD, Furler SM, Cooney GJ, Kraegen EW.

Diabetologia. 2004 Jul;47(7):1306-13. Epub 2004 Jul 1.

PMID:
15232684
[PubMed - indexed for MEDLINE]
7.

Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats.

Zhang CX, Pan SN, Meng RS, Peng CQ, Xiong ZJ, Chen BL, Chen GQ, Yao FJ, Chen YL, Ma YD, Dong YG.

Clin Exp Pharmacol Physiol. 2011 Jan;38(1):55-62. doi: 10.1111/j.1440-1681.2010.05461.x.

PMID:
21083698
[PubMed - indexed for MEDLINE]
8.

[Therapeutic effects of insulin-sensitizing drugs on nonalcoholic fatty liver disease: experiment with rats].

Zhang DM, Zhang GY, Wang T, Zhong HJ, Chen WK.

Zhonghua Yi Xue Za Zhi. 2006 May 16;86(18):1279-83. Chinese.

PMID:
16796890
[PubMed - indexed for MEDLINE]
9.

Xanthine oxidoreductase inhibition causes reverse remodeling in rats with dilated cardiomyopathy.

Minhas KM, Saraiva RM, Schuleri KH, Lehrke S, Zheng M, Saliaris AP, Berry CE, Barouch LA, Vandegaer KM, Li D, Hare JM.

Circ Res. 2006 Feb 3;98(2):271-9. Epub 2005 Dec 15. Erratum in: Circ Res. 2006 May 12;98(9):e70. Barouch, Lili A [added].

PMID:
16357304
[PubMed - indexed for MEDLINE]
Free Article
10.

Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction.

Shiomi T, Tsutsui H, Hayashidani S, Suematsu N, Ikeuchi M, Wen J, Ishibashi M, Kubota T, Egashira K, Takeshita A.

Circulation. 2002 Dec 10;106(24):3126-32.

PMID:
12473562
[PubMed - indexed for MEDLINE]
Free Article
11.

Metformin treatment corrects vascular insulin resistance in hypertension.

Verma S, Yao L, Dumont AS, McNeill JH.

J Hypertens. 2000 Oct;18(10):1445-50.

PMID:
11057432
[PubMed - indexed for MEDLINE]
12.

Chronic glucagon-like peptide-1 infusion sustains left ventricular systolic function and prolongs survival in the spontaneously hypertensive, heart failure-prone rat.

Poornima I, Brown SB, Bhashyam S, Parikh P, Bolukoglu H, Shannon RP.

Circ Heart Fail. 2008 Sep;1(3):153-60. doi: 10.1161/CIRCHEARTFAILURE.108.766402.

PMID:
19727407
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats.

Bartha E, Solti I, Kereskai L, Lantos J, Plozer E, Magyar K, Szabados E, Kálai T, Hideg K, Halmosi R, Sumegi B, Toth K.

Cardiovasc Res. 2009 Aug 1;83(3):501-10. doi: 10.1093/cvr/cvp144. Epub 2009 May 14.

PMID:
19443425
[PubMed - indexed for MEDLINE]
Free Article
14.

The peroxisome proliferator-activated receptor-alpha (PPAR-alpha) agonist, AVE8134, attenuates the progression of heart failure and increases survival in rats.

Linz W, Wohlfart P, Baader M, Breitschopf K, Falk E, Schäfer HL, Gerl M, Kramer W, Rütten H.

Acta Pharmacol Sin. 2009 Jul;30(7):935-46. doi: 10.1038/aps.2009.58. Epub 2009 Jun 8.

PMID:
19503102
[PubMed - indexed for MEDLINE]
Free Article
15.

Insulin sensitization therapy and the heart: focus on metformin and thiazolidinediones.

Wong AK, Struthers AD, Choy AM, Lang CC.

Heart Fail Clin. 2012 Oct;8(4):539-50. doi: 10.1016/j.hfc.2012.06.002. Epub 2012 Aug 9. Review.

PMID:
22999238
[PubMed - indexed for MEDLINE]
16.

Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure.

Peterson JT, Hallak H, Johnson L, Li H, O'Brien PM, Sliskovic DR, Bocan TM, Coker ML, Etoh T, Spinale FG.

Circulation. 2001 May 8;103(18):2303-9.

PMID:
11342481
[PubMed - indexed for MEDLINE]
Free Article
17.

The myocardial beta-adrenergic system in spontaneously hypertensive heart failure (SHHF) rats.

Anderson KM, Eckhart AD, Willette RN, Koch WJ.

Hypertension. 1999 Jan;33(1 Pt 2):402-7.

PMID:
9931137
[PubMed - indexed for MEDLINE]
Free Article
18.

Cardiac fibrosis and vascular remodeling are attenuated by metformin in obese rats.

Burlá AK, Lobato NS, Fortes ZB, Oigman W, Neves MF.

Int J Cardiol. 2013 May 25;165(3):483-7. doi: 10.1016/j.ijcard.2011.09.012. Epub 2011 Sep 25.

PMID:
21945710
[PubMed - indexed for MEDLINE]
Free Article
19.

Selective ETA receptor blockade prevents left ventricular remodeling and deterioration of cardiac function in experimental heart failure.

Mulder P, Richard V, Bouchart F, Derumeaux G, Münter K, Thuillez C.

Cardiovasc Res. 1998 Sep;39(3):600-8.

PMID:
9861302
[PubMed - indexed for MEDLINE]
Free Article
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk